Home › Compare › BMXMF vs SBUX

BMXMF vs SBUX: Dividend Comparison 2026

BMXMF yields 1.00% · SBUX yields 2.75%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BMXMF wins by $4.46M in total portfolio value· pulled ahead in Year 5
10 years
BMXMF
BMXMF
● Live price
1.00%
Share price
$102.25
Annual div
$1.03
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.62M
Annual income
$3,874,899.32
Full BMXMF calculator →
SBUX
SBUX
● Live price
2.75%
Share price
$89.59
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$157.5K
Annual income
$65,840.13
Full SBUX calculator →

Portfolio growth — BMXMF vs SBUX

📍 BMXMF pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBMXMFSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BMXMF + SBUX cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
BMXMF pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BMXMF
Annual income on $10K today (after 15% tax)
$85.29/yr
After 10yr DRIP, annual income (after tax)
$3,293,664.42/yr
SBUX
Annual income on $10K today (after 15% tax)
$233.40/yr
After 10yr DRIP, annual income (after tax)
$55,964.11/yr
At 15% tax rate, BMXMF beats the other by $3,237,700.31/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BMXMF + SBUX for your $10,000?

BMXMF: 50%SBUX: 50%
100% SBUX50/50100% BMXMF
Portfolio after 10yr
$2.39M
Annual income
$1,970,369.72/yr
Blended yield
82.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

BMXMF
Analyst Ratings
4
Buy
1
Hold
Consensus: Buy
Altman Z
6.7
Piotroski
7/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+16.1% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BMXMF buys
0
SBUX buys
0
No recent congressional trades found for BMXMF or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBMXMFSBUX
Forward yield1.00%2.75% ✓
Annual dividend / share$1.03$2.46 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100% ✓48.3%
Portfolio after 10y$4.62M$157.5K ✓
Annual income after 10y$3,874,899.32 ✓$65,840.13
Total dividends collected$4.53M$127.5K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyBuy

Year-by-year: BMXMF vs SBUX ($10,000, DRIP)

YearBMXMF PortfolioBMXMF Income/yrSBUX PortfolioSBUX Income/yrGap
1$10,901$200.68$11,107$407.21$206.00 → SBUX
2$12,073$408.90$12,512$626.87$439.00 → SBUX
3$13,764$846.46$14,366$978.69$602.00 → SBUX
4$16,532$1,803.86$16,929$1,557.50$397.00 → SBUX
5← crossover$21,738$4,049.60$20,658$2,543.80+$1.1K → BMXMF
6$33,213$9,953.40$26,406$4,302.22+$6.8K → BMXMF
7$63,964$28,425.29$35,877$7,622.00+$28.1K → BMXMF
8$170,764$102,322.42$52,741$14,352.64+$118.0K → BMXMF
9$693,315$510,597.75$85,676$29,243.03+$607.6K → BMXMF
10$4,616,746$3,874,899.32$157,513$65,840.13+$4.46M → BMXMF

BMXMF vs SBUX: Complete Analysis 2026

BMXMF — Stock

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Full BMXMF Calculator →

SBUX — Consumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this BMXMF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BMXMF vs SCHDBMXMF vs JEPIBMXMF vs OBMXMF vs KOBMXMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.